Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-25

Clinical Trial Update: Glycine and Magnesium+Thiamine for the Treatment of Primary Ciliary Dyskinesia [NA]

View source ↗

Summary

A clinical trial is recruiting to evaluate glycine and a magnesium plus thiamine combination for treating primary ciliary dyskinesia. The study is sponsored by …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glycine (glycine)
  • Magnesium + Thiamine (magnesium thiamine)

Snippet

Sponsor: Instituto Nacional de Enfermedades Respiratorias | Conditions: Primary Ciliary Dyskinesia | NA | Status: RECRUITING